Venetoclax And Other New Kids On The Block Shine At ASH
Emerging drugs for chronic lymphocytic leukemia include Roche/AbbVie’s venetoclax (ABT-199), Acerta’s ACP-196, Merck’s Keytruda and MorPhoSys’ MOR208.
Emerging drugs for chronic lymphocytic leukemia include Roche/AbbVie’s venetoclax (ABT-199), Acerta’s ACP-196, Merck’s Keytruda and MorPhoSys’ MOR208.